There are 749 resources available
PAGA for locally advanced lung cancer: Review of adapted recommendations for locally advanced lung cancer
Presenter: Keunchil Park
Session: Pan Asia Adapted ESMO Guidelines: Adaptation of ESMO guidelines in Asia
Resources:
Slides
Webcast
The way forward: Other ESMO guidelines to adapt in 2020 - Perspective and challenges
Presenter: George Pentheroudakis
Session: Pan Asia Adapted ESMO Guidelines: Adaptation of ESMO guidelines in Asia
Resources:
Slides
Webcast
Overview of the ESMO Precision Medicine Working Group accomplishments in 2018/19
Presenter: Fabrice André
Session: ESMO - AACR Collaborative Session: Challenges in the use of genomics platforms
Resources:
Slides
Webcast
Building a scalable genomic medicine programme: MSK IMPACT experience
Presenter: Michael Berger
Session: ESMO - AACR Collaborative Session: Challenges in the use of genomics platforms
Resources:
Slides
Webcast
Pragmatic considerations for implementing molecular profiling
Presenter: Kenna R. Mills Shaw
Session: ESMO - AACR Collaborative Session: Challenges in the use of genomics platforms
Resources:
Slides
Webcast
PAGA for hepatocellular carcinoma: Review of adapted recommendations for HCC
Presenter: LI- TZONG CHEN
Session: Pan Asia Adapted ESMO Guidelines: Adaptation of ESMO guidelines in Asia
Resources:
Slides
PAGA for early breast cancer: Case presentation
Presenter: Koung Jin Suh
Session: Pan Asia Adapted ESMO Guidelines: Adaptation of ESMO guidelines in Asia
Resources:
Slides
Webcast
Survival and treatment patterns in patients (pts) with locally advanced or metastatic NSCLC treated with epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIS): Analysis of US insurance claims databases
Presenter: Ross Soo
Session: Mini Oral session - Thoracic cancers
Resources:
Slides
Webcast
Updated overall survival (OS) from extended follow up in ARCHER 1050: A randomized phase III study comparing dacomitinib with gefitinib as first-line therapy for patients (pts) with EGFR mutations
Presenter: Tony S.K. Mok
Session: Mini Oral session - Thoracic cancers
Resources:
Slides
Webcast
A phase I study to evaluate safety and efficacy of BPI-7711 in EGFRm+/T790M+ advanced or recurrent NSCLC patients
Presenter: Sheng Yang
Session: Mini Oral session - Thoracic cancers
Resources:
Slides
Webcast